JP2024535729A5 - - Google Patents
Info
- Publication number
- JP2024535729A5 JP2024535729A5 JP2024513722A JP2024513722A JP2024535729A5 JP 2024535729 A5 JP2024535729 A5 JP 2024535729A5 JP 2024513722 A JP2024513722 A JP 2024513722A JP 2024513722 A JP2024513722 A JP 2024513722A JP 2024535729 A5 JP2024535729 A5 JP 2024535729A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid construct
- cells
- virus
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163240297P | 2021-09-02 | 2021-09-02 | |
| US63/240,297 | 2021-09-02 | ||
| PCT/US2022/075853 WO2023034927A1 (en) | 2021-09-02 | 2022-09-01 | Modified alphaviruses with heterologous nonstructural proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024535729A JP2024535729A (ja) | 2024-10-02 |
| JP2024535729A5 true JP2024535729A5 (https=) | 2025-09-08 |
Family
ID=85413097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513722A Pending JP2024535729A (ja) | 2021-09-02 | 2022-09-01 | 異種非構造タンパク質を有する改変アルファウイルス |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240400619A1 (https=) |
| EP (1) | EP4396359A4 (https=) |
| JP (1) | JP2024535729A (https=) |
| KR (1) | KR20240051229A (https=) |
| CN (1) | CN118119714A (https=) |
| AU (1) | AU2022339954A1 (https=) |
| CA (1) | CA3230407A1 (https=) |
| IL (1) | IL311112A (https=) |
| WO (1) | WO2023034927A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024279218A1 (en) * | 2023-05-26 | 2026-01-15 | Replicate Bioscience, Inc. | Compositions and methods for expression of il-1ra and il-18bp |
| WO2025144717A1 (en) * | 2023-12-27 | 2025-07-03 | Replicate Bioscience, Inc. | Compositions and methods for inducing immune response against epstein-barr viruses |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6458560B1 (en) * | 1996-04-05 | 2002-10-01 | Chiron Corporation | Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| US5811407A (en) * | 1997-02-19 | 1998-09-22 | The University Of North Carolina At Chapel Hill | System for the in vivo delivery and expression of heterologous genes in the bone marrow |
| CN111163799A (zh) * | 2017-07-28 | 2020-05-15 | 扬森疫苗与预防公司 | 用于异源repRNA免疫接种的方法和组合物 |
| JP7494117B2 (ja) * | 2018-01-19 | 2024-06-03 | ヤンセン ファーマシューティカルズ，インコーポレーテッド | 組換えレプリコン系を使用する免疫応答の誘導および増強 |
-
2022
- 2022-09-01 US US18/688,697 patent/US20240400619A1/en active Pending
- 2022-09-01 JP JP2024513722A patent/JP2024535729A/ja active Pending
- 2022-09-01 WO PCT/US2022/075853 patent/WO2023034927A1/en not_active Ceased
- 2022-09-01 CA CA3230407A patent/CA3230407A1/en active Pending
- 2022-09-01 KR KR1020247010357A patent/KR20240051229A/ko active Pending
- 2022-09-01 IL IL311112A patent/IL311112A/en unknown
- 2022-09-01 AU AU2022339954A patent/AU2022339954A1/en active Pending
- 2022-09-01 CN CN202280070364.XA patent/CN118119714A/zh active Pending
- 2022-09-01 EP EP22865809.2A patent/EP4396359A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2220964C (en) | Alphavirus rna replicon systems | |
| JP2024535729A5 (https=) | ||
| CA2518546A1 (en) | Improved alphavirus replicons and helper constructs | |
| BR112021006614A2 (pt) | replicons com base em alfavírus para administração de bioterápicos | |
| CA2188421A1 (en) | Alphavirus expression vector | |
| US11613561B2 (en) | Artificial alphavirus-derived RNA replicon expression systems | |
| JP2024544623A5 (https=) | ||
| US20260109975A1 (en) | Self-replicating rna and use thereof | |
| US20060099587A1 (en) | Alphavirus vectors having attentuated virion structural proteins | |
| KR20230009324A (ko) | 폴리뉴클레오타이드 및 이의 용도 | |
| WO2026041140A1 (zh) | 一种自复制rna分子及其制备方法和应用 | |
| Austin | Modifications of Alphavirus Replicon Vaccine Platforms: A Literature Review | |
| US20080096274A1 (en) | Recombinant alphavirus vectors and methods of using same | |
| WO2025157249A1 (zh) | 一种自复制rna及其用途 | |
| KR100457791B1 (ko) | 암억제 단백질을 발현하는 알파바이러스계 발현 벡터, 이의 제조 방법 및 용도 | |
| WO2025153828A1 (en) | Protein replacement therapy | |
| JP2025514774A5 (https=) | ||
| EP4469583A1 (en) | Methods for generating functional self-replicating rna molecules | |
| WO2004000872A2 (en) | Improved alphavirus vectors having attenuated virion structural proteins | |
| Voikov et al. | ALPHAVIRUSES: MOLECULAR BIOLOGY AND PRACTICAL APPLICATIONS | |
| WO2010002854A2 (en) | Large capacity gene delivery system | |
| KR20040077600A (ko) | 암억제 단백질을 발현하는 알파바이러스계 발현 벡터,이의 제조 방법 및 용도 |